Guidance on the application of the revised variations framework
Submitted by Anonymous (not verified) on 22 September 2025 - 13:02
Guidance on the application of the revised variations framework
Agenda of the HMPC meeting 22-24 September 2025
Submitted by Anonymous (not verified) on 22 September 2025 - 12:39
Agenda of the HMPC meeting 22-24 September 2025
CHMP PROM minutes for the meeting on 17 March 2025
Submitted by Anonymous (not verified) on 22 September 2025 - 11:14
CHMP PROM minutes for the meeting on 17 March 2025
Agenda – Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 24 September 2025
Submitted by Anonymous (not verified) on 22 September 2025 - 10:50
Agenda – Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - 24 September 2025
Herbal medicinal product: Combination: Species pectorales, F: Assessment finalised
Submitted by Anonymous (not verified) on 22 September 2025 - 10:44
Herbal medicinal product: Combination: Species pectorales, F: Assessment finalised
Mandate, objectives, and rules of procedure for working parties under the quality, non-clinical, methodology, clinical and veterinary domains
Submitted by Anonymous (not verified) on 22 September 2025 - 9:22
Mandate, objectives, and rules of procedure for working parties under the quality, non-clinical, methodology, clinical and veterinary domains
1st EMA/HMA multi-stakeholder forum on EudraVigilance and signal detection, European Medicines Agency, Amsterdam, the Netherlands, 5 November 2025
Submitted by Anonymous (not verified) on 19 September 2025 - 16:14
1st EMA/HMA multi-stakeholder forum on EudraVigilance and signal detection, European Medicines Agency, Amsterdam, the Netherlands, 5 November 2025
Referral: Ixchiq, Chikungunya vaccine (live) Article 20 procedures European Commission final decision, 24/07/2025, 12/09/2025, 19/09/2025
Submitted by Anonymous (not verified) on 19 September 2025 - 14:10
Referral: Ixchiq, Chikungunya vaccine (live) Article 20 procedures European Commission final decision, 24/07/2025, 12/09/2025, 19/09/2025
EVVet3 EVWeb Production - Release notes
Submitted by Anonymous (not verified) on 19 September 2025 - 11:30
EVVet3 EVWeb Production - Release notes
First treatment recommended for rare immunoglobulin-related autoimmune disease
Submitted by Anonymous (not verified) on 19 September 2025 - 11:00
First treatment recommended for rare immunoglobulin-related autoimmune disease